A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity

Overview of attention for article published in PLOS ONE, July 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

Grant US-10905757-B2

United States of America

Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

Grant US-10758609-B2

United States of America

Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

Grant US-9913895-B2

United States of America

VACCINES COMPRISING AN IMMUNOSTIMULATORY PEPTIDE AND AN IMMUNOSTIMULATORY…

Application US-20150010595-A1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.